Selected research
Industry Growth & Trends
Global Sodium Nitroprusside Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global Sodium Nitroprusside Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Sodium Nitroprusside Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Sodium Nitroprusside Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sodium Nitroprusside Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sodium Nitroprusside Injection include Yuekang Pharmaceutical Group, Kaifeng Connaught Pharmaceutical, Pfizer, China Resources Shuanghe Pharmaceutical, Slate Run Pharmaceuticals, Nexus Pharmaceuticals, Meitheal Pharmaceuticals, Exela Pharma Sciences and Akorn, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Sodium Nitroprusside Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Sodium Nitroprusside Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sodium Nitroprusside Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sodium Nitroprusside Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Sodium Nitroprusside Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Sodium Nitroprusside Injection Market by Company
Yuekang Pharmaceutical Group
Kaifeng Connaught Pharmaceutical
Pfizer
China Resources Shuanghe Pharmaceutical
Slate Run Pharmaceuticals
Nexus Pharmaceuticals
Meitheal Pharmaceuticals
Exela Pharma Sciences
Akorn, Inc.
Sodium Nitroprusside Injection Segment by Type
Dry Powder Injection
Liquid Injection
Sodium Nitroprusside Injection Segment by Application
Hospital
Clinic
Sodium Nitroprusside Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Nitroprusside Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sodium Nitroprusside Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Nitroprusside Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sodium Nitroprusside Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Sodium Nitroprusside Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dry Powder Injection
- Liquid Injection
Applications
- Hospital
- Clinic
Companies covered
- Yuekang Pharmaceutical Group
- Kaifeng Connaught Pharmaceutical
- Pfizer
- China Resources Shuanghe Pharmaceutical
- Slate Run Pharmaceuticals
- Nexus Pharmaceuticals
- Meitheal Pharmaceuticals
- Exela Pharma Sciences
- Akorn, Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Sodium Nitroprusside Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Sodium Nitroprusside Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Sodium Nitroprusside Injection Market by Type
- 1.3.1 Dry Powder Injection
- 1.3.2 Liquid Injection
- 1.4 Global Sodium Nitroprusside Injection Market Size by Type
- 1.4.1 Global Sodium Nitroprusside Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Sodium Nitroprusside Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Sodium Nitroprusside Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Sodium Nitroprusside Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Sodium Nitroprusside Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Sodium Nitroprusside Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Sodium Nitroprusside Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Sodium Nitroprusside Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Sodium Nitroprusside Injection Industry Trends
- 2.2 Sodium Nitroprusside Injection Industry Drivers
- 2.3 Sodium Nitroprusside Injection Industry Opportunities and Challenges
- 2.4 Sodium Nitroprusside Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Sodium Nitroprusside Injection Revenue (2021-2026)
- 3.2 Global Top Players by Sodium Nitroprusside Injection Sales (2021-2026)
- 3.3 Global Top Players by Sodium Nitroprusside Injection Price (2021-2026)
- 3.4 Global Sodium Nitroprusside Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sodium Nitroprusside Injection Major Company Production Sites & Headquarters
- 3.6 Global Sodium Nitroprusside Injection Company, Product Type & Application
- 3.7 Global Sodium Nitroprusside Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sodium Nitroprusside Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sodium Nitroprusside Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Sodium Nitroprusside Injection Tier 1, Tier 2, and Tier 3
4 Sodium Nitroprusside Injection Regional Status and Outlook
- 4.1 Global Sodium Nitroprusside Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Sodium Nitroprusside Injection Historic Market Size by Region
- 4.2.1 Global Sodium Nitroprusside Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Sodium Nitroprusside Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Sodium Nitroprusside Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Sodium Nitroprusside Injection Forecasted Market Size by Region
- 4.3.1 Global Sodium Nitroprusside Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Sodium Nitroprusside Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Sodium Nitroprusside Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sodium Nitroprusside Injection by Application
- 5.1 Sodium Nitroprusside Injection Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Sodium Nitroprusside Injection Market Size by Application
- 5.2.1 Global Sodium Nitroprusside Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Sodium Nitroprusside Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Sodium Nitroprusside Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Sodium Nitroprusside Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Sodium Nitroprusside Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Sodium Nitroprusside Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Sodium Nitroprusside Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Sodium Nitroprusside Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Yuekang Pharmaceutical Group
- 6.1.1 Yuekang Pharmaceutical Group Company Information
- 6.1.2 Yuekang Pharmaceutical Group Business Overview
- 6.1.3 Yuekang Pharmaceutical Group Sodium Nitroprusside Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Yuekang Pharmaceutical Group Sodium Nitroprusside Injection Product Portfolio
- 6.1.5 Yuekang Pharmaceutical Group Recent Developments
- 6.2 Kaifeng Connaught Pharmaceutical
- 6.2.1 Kaifeng Connaught Pharmaceutical Company Information
- 6.2.2 Kaifeng Connaught Pharmaceutical Business Overview
- 6.2.3 Kaifeng Connaught Pharmaceutical Sodium Nitroprusside Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Kaifeng Connaught Pharmaceutical Sodium Nitroprusside Injection Product Portfolio
- 6.2.5 Kaifeng Connaught Pharmaceutical Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Sodium Nitroprusside Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pfizer Sodium Nitroprusside Injection Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 China Resources Shuanghe Pharmaceutical
- 6.4.1 China Resources Shuanghe Pharmaceutical Company Information
- 6.4.2 China Resources Shuanghe Pharmaceutical Business Overview
- 6.4.3 China Resources Shuanghe Pharmaceutical Sodium Nitroprusside Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 China Resources Shuanghe Pharmaceutical Sodium Nitroprusside Injection Product Portfolio
- 6.4.5 China Resources Shuanghe Pharmaceutical Recent Developments
- 6.5 Slate Run Pharmaceuticals
- 6.5.1 Slate Run Pharmaceuticals Company Information
- 6.5.2 Slate Run Pharmaceuticals Business Overview
- 6.5.3 Slate Run Pharmaceuticals Sodium Nitroprusside Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Slate Run Pharmaceuticals Sodium Nitroprusside Injection Product Portfolio
- 6.5.5 Slate Run Pharmaceuticals Recent Developments
- 6.6 Nexus Pharmaceuticals
- 6.6.1 Nexus Pharmaceuticals Company Information
- 6.6.2 Nexus Pharmaceuticals Business Overview
- 6.6.3 Nexus Pharmaceuticals Sodium Nitroprusside Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Nexus Pharmaceuticals Sodium Nitroprusside Injection Product Portfolio
- 6.6.5 Nexus Pharmaceuticals Recent Developments
- 6.7 Meitheal Pharmaceuticals
- 6.7.1 Meitheal Pharmaceuticals Company Information
- 6.7.2 Meitheal Pharmaceuticals Business Overview
- 6.7.3 Meitheal Pharmaceuticals Sodium Nitroprusside Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Meitheal Pharmaceuticals Sodium Nitroprusside Injection Product Portfolio
- 6.7.5 Meitheal Pharmaceuticals Recent Developments
- 6.8 Exela Pharma Sciences
- 6.8.1 Exela Pharma Sciences Company Information
- 6.8.2 Exela Pharma Sciences Business Overview
- 6.8.3 Exela Pharma Sciences Sodium Nitroprusside Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Exela Pharma Sciences Sodium Nitroprusside Injection Product Portfolio
- 6.8.5 Exela Pharma Sciences Recent Developments
- 6.9 Akorn, Inc.
- 6.9.1 Akorn, Inc. Company Information
- 6.9.2 Akorn, Inc. Business Overview
- 6.9.3 Akorn, Inc. Sodium Nitroprusside Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Akorn, Inc. Sodium Nitroprusside Injection Product Portfolio
- 6.9.5 Akorn, Inc. Recent Developments
7 North America by Country
- 7.1 North America Sodium Nitroprusside Injection Sales by Country
- 7.1.1 North America Sodium Nitroprusside Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Sodium Nitroprusside Injection Sales by Country (2021-2026)
- 7.1.3 North America Sodium Nitroprusside Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Sodium Nitroprusside Injection Market Size by Country
- 7.2.1 North America Sodium Nitroprusside Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Sodium Nitroprusside Injection Market Size by Country (2021-2026)
- 7.2.3 North America Sodium Nitroprusside Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Sodium Nitroprusside Injection Sales by Country
- 8.1.1 Europe Sodium Nitroprusside Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Sodium Nitroprusside Injection Sales by Country (2021-2026)
- 8.1.3 Europe Sodium Nitroprusside Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Sodium Nitroprusside Injection Market Size by Country
- 8.2.1 Europe Sodium Nitroprusside Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Sodium Nitroprusside Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Sodium Nitroprusside Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Sodium Nitroprusside Injection Sales by Country
- 9.1.1 Asia-Pacific Sodium Nitroprusside Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Sodium Nitroprusside Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Sodium Nitroprusside Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Sodium Nitroprusside Injection Market Size by Country
- 9.2.1 Asia-Pacific Sodium Nitroprusside Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Sodium Nitroprusside Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Sodium Nitroprusside Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Sodium Nitroprusside Injection Sales by Country
- 10.1.1 South America Sodium Nitroprusside Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Sodium Nitroprusside Injection Sales by Country (2021-2026)
- 10.1.3 South America Sodium Nitroprusside Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Sodium Nitroprusside Injection Market Size by Country
- 10.2.1 South America Sodium Nitroprusside Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Sodium Nitroprusside Injection Market Size by Country (2021-2026)
- 10.2.3 South America Sodium Nitroprusside Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Sodium Nitroprusside Injection Sales by Country
- 11.1.1 Middle East and Africa Sodium Nitroprusside Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Sodium Nitroprusside Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Sodium Nitroprusside Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Sodium Nitroprusside Injection Market Size by Country
- 11.2.1 Middle East and Africa Sodium Nitroprusside Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Sodium Nitroprusside Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Sodium Nitroprusside Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Sodium Nitroprusside Injection Value Chain Analysis
- 12.1.1 Sodium Nitroprusside Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Sodium Nitroprusside Injection Production Mode & Process
- 12.2 Sodium Nitroprusside Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Sodium Nitroprusside Injection Distributors
- 12.2.3 Sodium Nitroprusside Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst